Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Thyroid Cancer
FDA Oncology Update
,
Thyroid Cancer
Gavreto Now Approved for Thyroid Cancer with RET Fusions
Read More
Thyroid Cancer
Thyroid Cancer Overview
Read More
Thyroid Cancer
Rearrangement During Transfection (RET) Fusions in Thyroid Cancers
Read More
Thyroid Cancer
Medullary Thyroid Cancer Overview
Read More
Thyroid Cancer
Papillary Thyroid Cancer Overview
Read More
Thyroid Cancer
Treatment for Advanced Thyroid Cancer
Read More
Lung Cancer
,
Thyroid Cancer
,
FDA Oncology Update
FDA Grants Priority Review to New Drug Application for the RET Kinase Inhibitor Selpercatinib
Read More
Results 1 - 7 of 7